SENORES logo

Senores Pharmaceuticals Limited Stock Price

NSEI:SENORES Community·₹35.9b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 6 Fair Values set on narratives written by author

SENORES Share Price Performance

₹780.40
223.35 (40.10%)
₹780.40
223.35 (40.10%)
Price ₹780.40

SENORES Community Narratives

There are no narratives available yet.

Snowflake Analysis

High growth potential with proven track record.

1 Risk
2 Rewards

Senores Pharmaceuticals Limited Key Details

₹5.2b

Revenue

₹2.2b

Cost of Revenue

₹2.9b

Gross Profit

₹2.1b

Other Expenses

₹871.2m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
Feb 14, 2026
18.92
56.80%
16.85%
27.8%
View Full Analysis

About SENORES

Founded
2017
Employees
194
CEO
Swapnil Shah
WebsiteView website
senorespharma.com

Senores Pharmaceuticals Limited develops, manufactures, sells, and trades in pharmaceutical and allied products in India, the United States, the United Kingdom, Canada, and internationally. It offers pharmaceutical solutions, such as analgesic/antipyretic, anesthetics and allied products, antibacterial/antibiotic, antiviral, antifungal, antioxidants, antineoplastic, blood line, cardiovascular, neurology, antacid, and vitamin and mineral preparation solutions; and analgesic/anti-inflammatory/antipyretic, anti-diabetic, antimalarial, neutral supplements, and urinary tract generics, as well as management and consultancy services. The company was incorporated in 2017 and is based in Ahmedabad, India.

Recent SENORES News & Updates

Recent updates

No updates